Abstract: A reusable accessory for a medication delivery device includes a housing, an adaptive element coupled to the housing and configured to reversibly attach to a medication delivery device received in the housing, and one or more attachment sensors configured to detect the adaptive element reversibly attaching to the medication delivery device. A method for detecting a medication delivery device in a reusable accessory includes determining, based on sensing data from one or more attachment sensors, whether the medication delivery device is reversibly attached, via an adaptable element, to a housing of the reusable accessory, and presenting, via at least one user interface, a status of the medication delivery device. A reusable accessory adaption kit comprises a first reusable accessory, a first adaptive element configured for reversibly attaching a first medication delivery device, and a second adaptive element configured for reversibly attaching a second medication delivery device.

Abstract: Medication delivery methods, devices and systems are provided. The medication delivery device includes a retractable sheath mechanism connected to a distal end of the device. The retractable sheath mechanism is axially movable between a first position to cover a needle attached to the distal end and a second position to expose the needle with an adjustable protrusion length. The retractable sheath mechanism includes one or more skin sensors disposed on an end surface thereof to detect skin before and during injection. In some cases, a needle carousel is provided to connect to the distal end of the device. The needle carousel supports multiple needle capsules each including a needle.

Abstract: A method of therapy escalation for patients with diabetes includes receiving glucose data of a user from an in vivo glucose monitoring device, receiving first therapy information of a first therapy, wherein the first therapy includes basal insulin, calculating one or more glucose metrics based on the received glucose data, titrating a dose of the basal insulin based on the one or more glucose metrics, and determining overbasalization based on one or more of the glucose data and the first therapy information. Advantageously the system can regularly monitor glucose control of a user, detect overbasalization, provide frequent therapy intervention and adjustment, decrease a duration of intervention, and increase user adherence, outcomes, and satisfaction.

Abstract: Described is drug infusion device and lineset for delivering medication. The novel pump and lineset described herein eliminate the ability of the pump and lineset from being primed when the cartridge reservoir is in fluid communication with the drug-delivering cannula, through which medication is delivered, is inserted into the skin of a patient. The system and method of the invention include a lineset having a plurality of electrical leads for allowing electrical communication between the infusion pump and the infusion set and for allowing the pump to determine whether the lineset is connected to the infusion set when a priming operation is initiated.

Abstract: The invention provides an insertion device for insertion of conduits into a body that, before and following deployment of the conduit into the body, has no components that require insertion into or removal from the device. Additionally, the device includes a component that not only prevents re-use or reopening of the device once it is activated, but also provides feedback to the user in the form of a resistance force to activation that must be overcome by the user to deploy the conduit.

Abstract: Described is drug infusion device and lineset for delivering medication. The novel pump and lineset described herein eliminate the ability of the pump and lineset from being primed when the cartridge reservoir is in fluid communication with the drug-delivering cannula, through which medication is delivered, is inserted into the skin of a patient. The system and method of the invention include a lineset having a plurality of electrical leads for allowing electrical communication between the infusion pump and the infusion set and for allowing the pump to determine whether the lineset is connected to the infusion set when a priming operation is initiated.

Abstract: The invention relates to a mechanical drive system for a medical infusion device. The disclosed drive system employs a flexible tape with recesses or holes that are configured to mate with tabs or protrusions on a gear to advance the rotation of the gear at a rate determined by the pattern of recesses or holes on the flexible tape.

Abstract: The invention provides an insertion device for insertion of conduits into a body that, before and following deployment of the conduit into the body, has no components that require insertion into or removal from the device. Additionally, the device includes a component that not only prevents re-use or reopening of the device once it is activated, but also provides feedback to the user in the form of a resistance force to activation that must be overcome by the user to deploy the conduit.

Abstract: The invention relates to a mechanical drive system for a medical infusion device. The disclosed drive system employs a flexible tape with recesses or holes that are configured to mate with tabs or protrusions on a gear to advance the rotation of the gear at a rate determined by the pattern of recesses or holes on the flexible tape.